Patents by Inventor Mark HIRSCHEL

Mark HIRSCHEL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10723993
    Abstract: A cell culture system for the production of cells and cell derived products includes a reusable instrumentation base device incorporating hardware to support cell culture growth. A disposable cultureware module including a cell growth chamber is removably attachable to the instrumentation base device. The base device includes microprocessor control and a pump for circulating cell culture medium through the cell growth chamber. The cultureware module is removably attached to the instrumentation base device. Cells are introduced into the cell growth chamber and a source of medium is fluidly attached to the cultureware module. Operating parameters are programmed into the microprocessor control. The pump is operated to circulate the medium through the cell growth chamber to grow cells or cell products therein. The grown cells or cell products are harvested from the cell growth chamber and the cultureware module is then disposed.
    Type: Grant
    Filed: August 24, 2016
    Date of Patent: July 28, 2020
    Assignee: BIOVEST INTERNATIONAL, INC.
    Inventors: Robert J. Wojciechowski, Darrell P. Page, Karl Patrick Bongers, Scott Waniger, Beverly Norris, Mark Hirschel, Thiem Chan Duong Wong, Grant Adams, Martin Peder Crep, Michael J. Gramer
  • Patent number: 10662401
    Abstract: The present invention provides a production module for large-scale production of cells and/or cell-derived products such as antibodies or virus; a production suite comprising a plurality of functionally connected production modules of the invention; and a method for large-scale production of cells and/or cell-derived products using the production modules and/or production suites of the invention.
    Type: Grant
    Filed: January 31, 2018
    Date of Patent: May 26, 2020
    Assignee: BIOVEST INTERNATIONAL, INC.
    Inventors: Mark Hirschel, Robert J. Wojciechowski, Kim Arneson
  • Patent number: 10570434
    Abstract: The subject invention pertains to methods and apparatus for the production and purification of cell products, such as immunoglobulins. One aspect of the invention is an integrated cell culture and purification apparatus for the growth and maintenance of cells and the harvest and purification of cell products, such as immunoglobulins. Thus, the apparatus integrates a cell culture function with a purification function. Other aspects of the invention pertain to an automated method for producing immunogenic compositions such as vaccines.
    Type: Grant
    Filed: January 31, 2018
    Date of Patent: February 25, 2020
    Assignee: BIOVEST INTERNATIONAL, INC.
    Inventors: Mark Hirschel, Robert J. Wojciechowski, Grant Adams, Darrell P. Page, Kimberly Arneson, Jeff Jorgensen, Scott Waniger
  • Patent number: 10093956
    Abstract: The subject invention pertains to methods and apparatus for the production and purification of cell products, such as immunoglobulins. One aspect of the invention is an integrated cell culture and purification apparatus for the growth and maintenance of cells and the harvest and purification of cell products, such as immunoglobulins. Thus, the apparatus integrates a cell culture function with a purification function. Other aspects of the invention pertain to an automated method for producing immunogenic compositions such as vaccines.
    Type: Grant
    Filed: October 17, 2014
    Date of Patent: October 9, 2018
    Assignee: BIOVEST INTERNATIONAL, INC.
    Inventors: Mark Hirschel, Robert J. Wojciechowski, Grant Adams, Darrell P. Page, Kimberly Arneson, Jeff Jorgensen, Scott Waniger
  • Publication number: 20180155752
    Abstract: The subject invention pertains to methods and apparatus for the production and purification of cell products, such as immunoglobulins. One aspect of the invention is an integrated cell culture and purification apparatus for the growth and maintenance of cells and the harvest and purification of cell products, such as immunoglobulins. Thus, the apparatus integrates a cell culture function with a purification function. Other aspects of the invention pertain to an automated method for producing immunogenic compositions such as vaccines.
    Type: Application
    Filed: January 31, 2018
    Publication date: June 7, 2018
    Inventors: MARK HIRSCHEL, ROBERT J. WOJCIECHOWSKI, GRANT ADAMS, DARRELL P. PAGE, KIMBERLY ARNESON, JEFF JORGENSEN, SCOTT WANIGER
  • Publication number: 20180155668
    Abstract: The present invention provides a production module for large-scale production of cells and/or cell-derived products such as antibodies or virus; a production suite comprising a plurality of functionally connected production modules of the invention; and a method for large-scale production of cells and/or cell-derived products using the production modules and/or production suites of the invention.
    Type: Application
    Filed: January 31, 2018
    Publication date: June 7, 2018
    Inventors: MARK HIRSCHEL, ROBERT J. WOJCIECHOWSKI, KIM ARNESON
  • Patent number: 9902928
    Abstract: The present invention provides a production module for large-scale production of cells and/or cell-derived products such as antibodies or virus; a production suite comprising a plurality of functionally connected production modules of the invention; and a method for large-scale production of cells and/or cell-derived products using the production modules and/or production suites of the invention.
    Type: Grant
    Filed: August 28, 2013
    Date of Patent: February 27, 2018
    Assignee: BIOVEST INTERNATIONAL, INC.
    Inventors: Mark Hirschel, Robert J. Wojciechowski, Kim Arneson
  • Patent number: 9732313
    Abstract: The invention concerns a bioreactor for production of virus and virus-like particles (VLPs), methods for production of virus and VLPs, methods for regulating the concentration of molecules inhibitory to viral and VLP yield in a cell culture chamber of a bioreactor, such as the extracapillary space of a hollow fiber bioreactor.
    Type: Grant
    Filed: October 30, 2014
    Date of Patent: August 15, 2017
    Assignee: BIOVEST INTERNATIONAL, INC.
    Inventors: Mark Hirschel, Joseph David Gangemi
  • Patent number: 9725768
    Abstract: The present invention concerns methods for selecting and producing idiotype vaccines, and in particular methods for selecting and producing an idiotype vaccine for treatment of a B-cell derived malignancy in a subject based on the clonal profile (clonotype) of the malignancy; a method for producing an updated idiotype vaccine matched to a B-cell derived malignancy exhibiting a shifting clonal profile; and the high-fidelity idiotype vaccines produced using the methods. The invention also includes idiotype vaccines produced using the described methods and methods of treating B-cell derived malignancies using the produced vaccines.
    Type: Grant
    Filed: August 30, 2013
    Date of Patent: August 8, 2017
    Assignee: BIOVEST INTERNATIONAL, INC.
    Inventors: Carlos F. Santos, Amy M. Mccord, Mark Hirschel
  • Publication number: 20160362650
    Abstract: A cell culture system for the production of cells and cell derived products includes a reusable instrumentation base device incorporating hardware to support cell culture growth. A disposable cultureware module including a cell growth chamber is removably attachable to the instrumentation base device. The base device includes microprocessor control and a pump for circulating cell culture medium through the cell growth chamber. The cultureware module is removably attached to the instrumentation base device. Cells are introduced into the cell growth chamber and a source of medium is fluidly attached to the cultureware module. Operating parameters are programmed into the microprocessor control. The pump is operated to circulate the medium through the cell growth chamber to grow cells or cell products therein. The grown cells or cell products are harvested from the cell growth chamber and the cultureware module is then disposed.
    Type: Application
    Filed: August 24, 2016
    Publication date: December 15, 2016
    Inventors: ROBERT J. WOJCIECHOWSKI, DARRELL P. PAGE, KARL PATRICK BONGERS, SCOTT WANIGER, BEVERLY NORRIS, MARK HIRSCHEL, THIEM CHAN DUONG WONG, GRANT ADAMS, MARTIN PEDER CREP, MICHAEL J. GRAMER
  • Patent number: 9441195
    Abstract: A cell culture system for the production of cells and cell derived products includes a reusable instrumentation base device incorporating hardware to support cell culture growth. A disposable cultureware module including a cell growth chamber is removably attachable to the instrumentation base device. The base device includes microprocessor control and a pump for circulating cell culture medium through the cell growth chamber. The cultureware module is removably attached to the instrumentation base device. Cells are introduced into the cell growth chamber and a source of medium is fluidly attached to the cultureware module. Operating parameters are programmed into the microprocessor control. The pump is operated to circulate the medium through the cell growth chamber to grow cells or cell products therein. The grown cells or cell products are harvested from the cell growth chamber and the cultureware module is then disposed.
    Type: Grant
    Filed: October 30, 2012
    Date of Patent: September 13, 2016
    Assignee: BIOVEST INTERNATIONAL, INC.
    Inventors: Robert J. Wojciechowski, Darrell P. Page, Karl Patrick Bongers, Scott Waniger, Beverly Norris, Mark Hirschel, Thiem Chan Duong Wong, Grant Adams, Martin Peder Crep, Michael J. Gramer
  • Publication number: 20150259749
    Abstract: The present invention concerns methods for selecting and producing idiotype vaccines, and in particular methods for selecting and producing an idiotype vaccine for treatment of a B-cell derived malignancy in a subject based on the clonal profile (clonotype) of the malignancy; a method for producing an updated idiotype vaccine matched to a B-cell derived malignancy exhibiting a shifting clonal profile; and the high-fidelity idiotype vaccines produced using the methods. The invention also includes idiotype vaccines produced using the described methods and methods of treating B-cell derived malignancies using the produced vaccines.
    Type: Application
    Filed: August 30, 2013
    Publication date: September 17, 2015
    Inventors: Carlos F. Santos, Amy M. Mccord, Mark Hirschel
  • Publication number: 20150225685
    Abstract: The present invention provides a production module for large-scale production of cells and/or cell-derived products such as antibodies or virus; a production suite comprising a plurality of functionally connected production modules of the invention; and a method for large-scale production of cells and/or cell-derived products using the production modules and/or production suites of the invention.
    Type: Application
    Filed: August 28, 2013
    Publication date: August 13, 2015
    Inventors: Mark Hirschel, Robert J. Wojciechowski, Kimberly Arneson
  • Publication number: 20150175950
    Abstract: The invention concerns a bioreactor for production of virus and virus-like particles (VLPs), methods for production of virus and VLPs, methods for regulating the concentration of molecules inhibitory to viral and VLP yield in a cell culture chamber of a bioreactor, such as the extracapillary space of a hollow fiber bioreactor.
    Type: Application
    Filed: October 30, 2014
    Publication date: June 25, 2015
    Inventors: MARK HIRSCHEL, ROBERT J. WOJCIECHOWSKI, JOSEPH DAVID GANGEMI, SCOTT WANIGER, KEVIN TACHENY, CHAD SINKLER, DARRELL P. PAGE, JEFF JORGENSEN, MICHAEL J. GRAMER, KIMBERLY ARNESON, GRANT ADAMS
  • Publication number: 20150111252
    Abstract: The subject invention pertains to methods and apparatus for the production and purification of cell products, such as immunoglobulins. One aspect of the invention is an integrated cell culture and purification apparatus for the growth and maintenance of cells and the harvest and purification of cell products, such as immunoglobulins. Thus, the apparatus integrates a cell culture function with a purification function. Other aspects of the invention pertain to an automated method for producing immunogenic compositions such as vaccines.
    Type: Application
    Filed: October 17, 2014
    Publication date: April 23, 2015
    Inventors: MARK HIRSCHEL, ROBERT J. WOJCIECHOWSKI, MICHAEL J. GRAMER, GRANT ADAMS, DARRELL P. PAGE, CHAD SINKLER, KEVIN TACHENY, KIMBERLY ARNESON, JEFF JORGENSEN, SCOTT WANIGER
  • Publication number: 20140140986
    Abstract: The present invention relates to compositions, kits, and methods useful for directing an immune response to an epitope of an antigen in a subject, by sensitizing the subject to the epitope and/or by tolerizing the subject to the epitope. The sensitizing method comprises co-administering to the subject the epitope and an immunoglobulin M (IgM) constant region (IgM Fc region). The tolerizing method comprises co-administering to the subject the epitope and an immunoglobulin G (IgG) constant region (IgG Fc region) to the subject.
    Type: Application
    Filed: November 8, 2011
    Publication date: May 22, 2014
    Applicant: BIOVEST INTERNATIONAL, INC.
    Inventors: Carlos F. Santos, Mihaela Popa-Mckiver, Amy M. Mccord, Mark Hirschel
  • Publication number: 20140037615
    Abstract: The present invention relates to compositions, kits, and methods for preparing an autologous idiotype vaccine, or autologous anti-idiotype vaccine, for treatment of a B-cell malignancy based on the isotype(s) (class(es)) of immunoglobulins expressed by the malignancy; methods for treating B-cell malignancies; and methods for selecting a treatment for a subject having a B-cell malignancy.
    Type: Application
    Filed: August 12, 2011
    Publication date: February 6, 2014
    Applicant: BIOVEST INTERNATIONAL, INC.
    Inventors: Carlos F. Santos, Mihaela Popa-Mckiver, Amy M. McCord, Mark Hirschel
  • Publication number: 20110212493
    Abstract: The present invention includes perfusion bioreactors, automated cell culture systems, and methods for production of cells and cell-derived products.
    Type: Application
    Filed: April 22, 2011
    Publication date: September 1, 2011
    Applicant: BIOVEST INTERNATIONAL, INC.
    Inventors: Mark HIRSCHEL, Darrell P. PAGE, Robert J. WOJCIECHOWSKI